See All Slides - tctmd.com

Slides

Presentation TCT 2014

Three Year Clinical Outcomes of a Unique Sirolimus-Eluting Stent with Fully Absorbable Polymer Coating: Long-term Results from the DESSOLVE I and the DESSOLVE II Clinical Trials_

Presenter: John Ormiston

September 16, 2014

Presentation TCT 2014

Impact of Intracoronary Injection of CD133+ Bone Marrow Stem Cells on Coronary Atherosclerotic Progression in Patients with STEMI: A COMPARE-AMI IVUS Substudy

Presenter: Fuyu Qiu

September 16, 2014

Presentation TCT 2014

Diamondback 360 Coronary Orbital Atherectomy System for Treating De Novo, Severely Calcified Coronary Lesions in Elderly Patients: 1-Year Results from the ORBIT II Trial

Presenter: Arthur Lee

September 16, 2014

Presentation TCT 2014

Evaluation of flow reversal during carotid artery stenting as the first choice for embolic protection - no contraindications!

Presenter: Marius Hornung

September 16, 2014

Presentation TCT 2014

Analysis of Quality of Life Decrements Associated with Changes in Angina Status in the ABSORB II Trial: First Randomized Comparison Between the Absorb? Everolimus Eluting___

Presenter: Bernard Chevalier

September 16, 2014

Presentation TCT 2014

Effect of Cangrelor on Ischemic Endpoints: Further Analyses from CHAMPION PHOENIX

Presenter: Deepak Bhatt

September 16, 2014

Presentation TCT 2014

Second generation devices for renal denervation give better renal blood flow when compared with 1st generation catheters

Presenter: Waleed Kadro

September 16, 2014

Presentation TCT 2014

The Impact of Wound Healing for Isolated Below the Knee Lesion Patients with Critical Limb Ischemia

Presenter: Masataka Kajiwara

September 16, 2014

Presentation TCT 2014

Abluminal biodegradable polymer biolimus-eluting stent versus durable polymer everolimus-eluting stent in patients undergoing primary percutaneous coronary intervention: 3 Year___

Presenter: Georgios Vlachojannis

September 16, 2014

Presentation TCT 2014

Long-Term Clinical Outcomes For Primary Angioplasty with Resolute Zotarolimus Eluting Stent in ST-Segment Elevation Acute Myocardial Infarction

Presenter: Carlo Di Mario

September 16, 2014

Advertisement

Slides

Three Year Clinical Outcomes of a Unique Sirolimus-Eluting Stent with Fully Absorbable Polymer Coating: Long-term Results from the DESSOLVE I and the DESSOLVE II Clinical Trials_

Impact of Intracoronary Injection of CD133+ Bone Marrow Stem Cells on Coronary Atherosclerotic Progression in Patients with STEMI: A COMPARE-AMI IVUS Substudy

Diamondback 360 Coronary Orbital Atherectomy System for Treating De Novo, Severely Calcified Coronary Lesions in Elderly Patients: 1-Year Results from the ORBIT II Trial

Evaluation of flow reversal during carotid artery stenting as the first choice for embolic protection - no contraindications!

Analysis of Quality of Life Decrements Associated with Changes in Angina Status in the ABSORB II Trial: First Randomized Comparison Between the Absorb? Everolimus Eluting___

Effect of Cangrelor on Ischemic Endpoints: Further Analyses from CHAMPION PHOENIX

Second generation devices for renal denervation give better renal blood flow when compared with 1st generation catheters

The Impact of Wound Healing for Isolated Below the Knee Lesion Patients with Critical Limb Ischemia

Abluminal biodegradable polymer biolimus-eluting stent versus durable polymer everolimus-eluting stent in patients undergoing primary percutaneous coronary intervention: 3 Year___

Long-Term Clinical Outcomes For Primary Angioplasty with Resolute Zotarolimus Eluting Stent in ST-Segment Elevation Acute Myocardial Infarction

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content